Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4EF9

Crystal structure of dihydroorotate dehydrogenase from Leishmania major in complex with 4-Nitrophenyl isothiocyanate

Summary for 4EF9
Entry DOI10.2210/pdb4ef9/pdb
Related4EF8
DescriptorDihydroorotate dehydrogenase, N-(4-nitrophenyl)thioformamide, FLAVIN MONONUCLEOTIDE, ... (6 entities in total)
Functional Keywordsleishmania major, dihydroorotate dehydrogenase, 4-nitrophenyl isothiocyanate, pyrd, oxidoreductase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor
Biological sourceLeishmania major
Total number of polymer chains2
Total formula weight78452.77
Authors
Pinheiro, M.P.,Emery, F.S.,Nonato, M.C. (deposition date: 2012-03-29, release date: 2012-12-12, Last modification date: 2024-10-16)
Primary citationPinheiro, M.P.,Emery, F.S.,Nonato, M.C.
Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase.
Curr.Pharm.Des., 19:2615-2627, 2013
Cited by
PubMed Abstract: Trypanosomatids consist of a large group of flagellated parasitic protozoa, including parasites from the genera Leishmania and Trypanosoma, responsible for causing infections in millions of humans worldwide and for which currently no appropriate therapy is available. The significance of pyrimidines in cellular metabolism makes their de novo and salvage pathways ideal druggable targets for pharmacological intervention and open an opportunity for pharmaceutical innovation. In the current review, we discuss the merits in targeting the enzyme dihydroorotate dehydrogenase (DHODH), a flavin-dependent enzyme that catalyzes the fourth and only redox step in pyrimidine de novo biosynthesis, as a strategy for the development of efficient therapeutic strategies for trypanosomatid-related diseases.We also describe the advances and perspectives from the structural biology point of view in order to unravel the structure-function relationship of trypanosomatid DHODHs, and to identify and validate target sites for drug development.
PubMed: 23116399
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon